Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
Part of paid clinical trials in Lakewood, California.
- Sponsor
- Raghu Nandan, M.D., Inc
- Study ID
- NCT00005825
- Phase
- PHASE2
- Status
- Unknown
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- cisplatin — DRUG
- mitomycin C — DRUG
- tretinoin — DRUG
- vinorelbine tartrate — DRUG
Study Details
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating patients who have stage IIIB or stage IV non-small cell lung cancer.
Key Dates
- Start date
- Sep 30, 1998
- Status verified
- Jul 2003
Study Design
- Primary purpose
- TREATMENT
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Rajendra Prasad M.D., Inc. | Lakewood | California | 90712 | - |
Find similar trials in Lakewood, CA
By condition
By specialty
By research site
Related Studies
- Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung CancersRecruiting · Stanford University · Stanford, California
- Studying Tumor Tissue Samples and Blood Samples to Learn More About DNA Changes in Patients With Lung CancerRecruiting · University of California, Davis · Sacramento, California
- Molecular Analysis of Thoracic MalignanciesEnrolling By Invitation · Stanford University · Stanford, California
- APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid TumorsPHASE2 · Recruiting · Apollomics Inc. · Los Angeles, California